Related Experiment Video
Updated: Jun 24, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3-Methylcrotonyl-CoA carboxylase deficiency: phenotypic variability in a family
F Tuba Eminoglu1, Aysima A Ozcelik, Ilyas Okur
1Department of Pediatric Metabolism and Nutrition, Gazi University Hospital, 10. floor, Beşevler, Ankara, Turkey. tubaeminoglu@yahoo.com.tr
Insights
3-methylcrotonyl-CoA carboxylase deficiency presents with varied symptoms, including seizures and developmental delays. This study details a family with this rare metabolic disorder, highlighting its broad phenotypic variability.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- 3-methylcrotonyl-CoA carboxylase deficiency is a rare inherited metabolic disorder.
- It affects the leucine degradation pathway.
- Clinical manifestations can vary widely.
Observation:
- A family presented with diverse clinical features attributed to 3-methylcrotonyl-CoA carboxylase deficiency.
- Affected individuals included a boy with atonic seizures, a brother with delayed language development, and an uncle with epilepsy.
- Biochemical analyses revealed elevated urinary organic acids and acylcarnitines, with reduced enzyme activity in fibroblasts.
Findings:
- A novel homozygous deletion in the MCCA gene was identified in the affected family members.
- The deletion (c.873+4524_6787de12264) resulted in significantly reduced MCC enzyme activity.
- Adult-onset afebrile seizures, a previously unreported presentation, were observed.
Implications:
- This study expands the known clinical spectrum of 3-methylcrotonyl-CoA carboxylase deficiency.
- It underscores the importance of considering this disorder in individuals with unexplained neurological symptoms.
- Genetic analysis is crucial for diagnosing this condition and understanding its variability.
Abstract:
A family with 3-methylcrotonyl-CoA carboxylase deficiency with different clinical features is described. A 15-month-old boy, who was the index patient, was admitted to the hospital with atonic seizure. His brother had delayed language development and their uncle had been followed with diagnosis of epilepsy for the last 5 years. Urinary organic acid analysis displayed elevated 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, analysis of acylcarnitines showed elevated 3-hydroxyisovalerylcarnitine and decreased free carnitine levels in both the patients and their uncle. Methylcrotonyl-CoA carboxylase activity in cultured fibroblasts displayed a low residual activity of 2.2% of the median control value while propionyl-CoA carboxylase activity was normal in the index patient. Mutation analysis revealed a large homozygous deletion of 2264 bp (c.873+4524_6787de12264) in the MCCA gene, which has not been described to date. Adult-onset afebrile seizures have not been reported in the literature. Our cases are an example of this wide phenotypic variability within a single family.
Related Concept Videos
Inborn Errors of Metabolism
Pedigree Analysis
Animal Mitochondrial Genetics
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Amino Acid Catabolism
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids

